Lung Cancer Screening, Version 1.2020

This is a clinical practice guideline for patients with lung cancer, especially adenocarcinoma. The guideline examines low-dose CT (LDCT) screening of these patients, including the accuracy of LDCT protocols and imaging modalities, and the benefits and risks of LDCT. Risk factors, nonsolid nodules, cost-effectiveness, and the selection of individuals for screening based on risk factors are also discussed.